Oxygenta Pharmaceutical Ltd

₹ 88.3 -2.00%

23 Dec - close price

About

Incorporated in 1990, Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine Chemicals.

Key Points

Products:^[1]
Losartan potassium intermediate, Gabapentin intermediate, Antihypertensive drugs, Anti
cancer drugs, Antiulcer drugs, Antiretroviral drugs, Antihypertensive drugs, Antiviral drugs.

Website BSE

Market Cap ₹ 313 Cr.
Current Price ₹ 88.3
High / Low ₹ 109 / 26.0
Stock P/E
Book Value ₹ -5.96
Dividend Yield 0.00 %
ROCE -41.8 %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is expected to give good quarter
Promoter holding has increased by 19.6% over last quarter.

Cons

Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	15.49	15.93	7.08	8.89	6.06	7.85	8.19	6.86	13.08	9.15	10.55	12.62	14.01
	14.54	15.09	8.52	9.93	7.56	10.18	10.44	10.50	15.06	11.63	12.17	14.40	16.18
Operating Profit	0.95	0.84	-1.44	-1.04	-1.50	-2.33	-2.25	-3.64	-1.98	-2.48	-1.62	-1.78	-2.17
OPM %	6.13%	5.27%	-20.34%	-11.70%	-24.75%	-29.68%	-27.47%	-53.06%	-15.14%	-27.10%	-15.36%	-14.10%	-15.49%
	-0.81	0.00	1.19	0.00	-0.34	-0.32	-0.05	-0.13	-0.03	-0.02	0.26	0.02	0.75
Interest	0.30	0.22	0.16	0.25	0.10	0.20	0.94	0.29	0.34	0.36	0.59	0.41	0.69
Depreciation	0.40	0.40	0.38	0.40	0.40	0.40	0.85	0.50	0.83	0.69	0.64	0.65	0.66
Profit before tax	-0.56	0.22	-0.79	-1.69	-2.34	-3.25	-4.09	-4.56	-3.18	-3.55	-2.59	-2.82	-2.77
Tax %	0.00%	0.00%	15.19%	0.00%	0.00%	0.00%	4.89%	0.00%	-0.63%	6.48%	-409.27%	-51.42%	2.89%
	-0.56	0.22	-0.91	-1.69	-2.34	-3.25	-4.29	-4.56	-3.16	-3.78	8.02	-1.36	-2.85
EPS in Rs	-0.39	0.15	-0.64	-1.19	-1.65	-2.29	-3.02	-1.36	-0.94	-1.13	2.40	-0.38	-0.80
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
	0.00	2.43	6.12	12.32	8.15	12.87	20.51	13.72	52.03	60.52	30.99	39.64	46.33
	1.45	5.89	10.24	16.49	12.99	16.87	22.54	21.59	48.19	59.05	38.11	49.34	54.38
Operating Profit	-1.45	-3.46	-4.12	-4.17	-4.84	-4.00	-2.03	-7.87	3.84	1.47	-7.12	-9.70	-8.05
OPM %		-142.39%	-67.32%	-33.85%	-59.39%	-31.08%	-9.90%	-57.36%	7.38%	2.43%	-22.98%	-24.47%	-17.38%
	-0.22	0.23	0.01	0.00	0.62	1.36	0.31	4.02	2.28	0.55	-0.71	0.08	1.01
Interest	0.00	0.01	0.21	0.51	0.60	0.90	0.75	1.09	1.78	0.92	1.49	1.59	2.05
Depreciation	0.00	0.86	2.53	0.82	0.90	0.94	1.02	1.00	1.20	1.59	2.05	2.66	2.64
Profit before tax	-1.67	-4.10	-6.85	-5.50	-5.72	-4.48	-3.49	-5.94	3.14	-0.49	-11.37	-13.87	-11.73
Tax %	0.00%	4.63%	-10.80%	0.00%	1.57%	1.12%	-6.88%	-2.53%	6.69%	24.49%	1.76%	-74.91%
	-1.67	-4.29	-6.11	-5.50	-5.81	-4.53	-3.25	-5.79	2.93	-0.61	-11.57	-3.48	0.03
EPS in Rs	-1.64	-4.21	-5.99	-5.39	-5.70	-4.44	-3.19	-5.68	2.87	-0.43	-8.15	-1.04	0.09
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	32%
5 Years:	14%
3 Years:	-9%
TTM:	29%

Compounded Profit Growth
10 Years:	2%
5 Years:	-2%
3 Years:	%
TTM:	99%

Stock Price CAGR
10 Years:	27%
5 Years:	%
3 Years:	47%
1 Year:	180%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	10.20	10.20	10.20	10.20	10.20	10.20	10.20	10.20	10.20	14.20	14.20	33.48	35.48
Reserves	-15.19	-19.48	-26.27	-31.77	-37.58	-42.11	-45.36	-51.15	-48.22	-48.83	-60.40	-53.61	-56.62
	8.11	10.62	14.67	17.36	19.25	19.15	22.34	26.92	47.89	52.13	68.00	57.24	60.62
	13.66	16.85	19.49	23.98	27.20	29.73	33.98	32.65	24.00	13.67	32.47	26.08	33.77
Total Liabilities	16.78	18.19	18.09	19.77	19.07	16.97	21.16	18.62	33.87	31.17	54.27	63.19	73.25
	12.36	15.75	11.55	12.80	12.45	12.29	11.90	11.42	16.31	19.98	27.91	29.36	29.83
CWIP	2.53	0.00	0.06	0.07	0.43	0.06	0.00	0.00	0.65	0.34	0.00	0.00	0.00
Investments	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
	1.84	2.39	6.43	6.85	6.14	4.57	9.21	7.15	16.86	10.80	26.31	33.78	43.37
Total Assets	16.78	18.19	18.09	19.77	19.07	16.97	21.16	18.62	33.87	31.17	54.27	63.19	73.25

Cash Flows

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	-0.61	-2.69	-4.28	0.85	0.52	1.28	-7.79	-2.59	-1.62	-1.68	-1.63	-13.05
	-2.57	-1.62	0.93	-2.08	-0.90	-0.39	-0.56	-0.50	-6.72	-4.94	-9.64	-4.09
	3.77	3.73	3.42	1.17	0.39	-0.90	8.36	3.19	8.67	6.33	11.22	17.13
Net Cash Flow	0.59	-0.58	0.07	-0.06	0.01	-0.01	0.01	0.10	0.33	-0.29	-0.05	-0.01

Ratios

Figures in Rs. Crores

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days		127.67	38.17	43.85	38.52	13.61	9.08	11.17	11.29	9.53	119.66	67.77
Inventory Days		33.18	83.74	40.95	121.67	57.34	120.99	99.57	120.67	56.27	178.02	149.35
Days Payable		10,164.70	1,799.72	666.60	599.27	395.51	203.16	189.76	137.41	49.93	361.50	249.18
Cash Conversion Cycle		-10,003.84	-1,677.80	-581.80	-439.09	-324.55	-73.09	-79.02	-5.45	15.87	-63.82	-32.05
Working Capital Days		-1,575.66	-616.09	-454.47	-511.90	-430.80	-155.54	-261.25	5.89	14.60	-26.62	-13.44
ROCE %	-70.05%	-187.89%								-0.88%	-46.56%	-41.83%

Shareholding Pattern

Numbers in percentages

5 Recently

	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	12.33%	12.33%	12.33%	12.34%	12.34%	8.99%	26.80%	29.73%	29.73%	29.73%	33.68%	53.28%
	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
	87.60%	87.60%	87.60%	87.60%	87.60%	90.95%	73.18%	70.24%	70.24%	70.24%	66.28%	46.69%
No. of Shareholders	8,873	9,038	9,004	9,000	9,101	8,995	8,987	8,972	9,051	10,102	9,970	10,154

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
	36.78%	36.78%	17.17%	17.17%	17.17%	12.33%	8.99%	29.73%	53.28%
	0.10%	0.10%	0.10%	0.10%	0.10%	0.07%	0.07%	0.03%	0.03%
	63.13%	63.13%	82.73%	82.73%	82.73%	87.60%	90.95%	70.24%	46.69%
No. of Shareholders	8,852	8,814	8,771	8,758	8,762	9,038	8,995	10,102	10,154

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports